An unfavourable environment weighs on OWENS & MINOR, which sees a downgrade to Slightly Negative
The independent financial analyst theScreener just requalified the general evaluation of OWENS & MINOR (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date October 19, 2021, the closing price was USD 33.20 and its target price was estimated at USD 23.77.Owens & Minor is a healthcare solutions company. The company provides products and services to healthcare provider, manufacturers and directly to patients across the continuum of care. The company has two segments: Global Solutions, which provides a portfolio of medical and surgical supplies and service offerings to healthcare providers including supplier management, analytics, inventory management, and clinical supply management; and Global Products, which manufactures and sources medical surgical products through its production and kitting operations as well as provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.